The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/2DBAA4C8.svg?ark=w1%2F20260515%2F2DBAA4C8)](https://nobleid.org/work/w1/20260515/2DBAA4C8)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors